BE902475A - BIOLOGICALLY ACTIVE TRIDECAPEPTIDES. - Google Patents
BIOLOGICALLY ACTIVE TRIDECAPEPTIDES.Info
- Publication number
- BE902475A BE902475A BE0/215051A BE215051A BE902475A BE 902475 A BE902475 A BE 902475A BE 0/215051 A BE0/215051 A BE 0/215051A BE 215051 A BE215051 A BE 215051A BE 902475 A BE902475 A BE 902475A
- Authority
- BE
- Belgium
- Prior art keywords
- pro
- alkoxycarbonyl
- alkyl
- aralkoxycarbonyl
- aralkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Des peptides répondant à la formule Glp-X-Lys-Pro-Tyr-Trp-Pro-Pro-Pro-Y-Tyr-Pro-W-C où X = L-alpha-amino-acide neutre ou acide; A = H ou groupe acyle, alcoxycarbonyle, aralcoxycarbonyle, alkyle ou aralkyle protecteur du groupe amino; B = H ou groupe acyle, alkyle, aralkyle, alcoxycarbonyle ou aralcoxycarbonyle protecteur du groupe hydroxy phénolique; Y et W = L -alpha-amino-acide neutre; C = OH, amino ou Or, NHR, NHR, NR2 ou NH-NH-R' ; R = alkyle en C1- C11, phényle ou aralkyle en C7-C14 et R' = H, R, acyle aliphatique en C1-C11, alcoxycarbonyle en C3-C11 ou aralcoxycarbonyle.Les peptides synthétisées sont utiles dans des procédés de traitement thérapeutique chez l'homme ou l'animal et notamment une stimulation de la sécrétion de la prolactine prituitaire, elles exercent des effets sédatifs inhibant le transit intestinal, et sont antipyrétiques.Peptides corresponding to the formula Glp-X-Lys-Pro-Tyr-Trp-Pro-Pro-Pro-Y-Tyr-Pro-W-C where X = L-alpha-amino acid neutral or acid; A = H or acyl, alkoxycarbonyl, aralkoxycarbonyl, alkyl or aralkyl group protecting the amino group; B = H or acyl, alkyl, aralkyl, alkoxycarbonyl or aralkoxycarbonyl group protecting the phenolic hydroxy group; Y and W = L -alpha-amino acid neutral; C = OH, amino or Gold, NHR, NHR, NR2 or NH-NH-R '; R = C1-C11 alkyl, phenyl or C7-C14 aralkyl and R '= H, R, C1-C11 aliphatic acyl, C3-C11 alkoxycarbonyl or aralkoxycarbonyl. The synthesized peptides are useful in therapeutic treatment processes in humans or animals, and in particular stimulation of the secretion of prolactin proliferative, they exert sedative effects inhibiting intestinal transit, and are antipyretic.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB848413272A GB8413272D0 (en) | 1984-05-24 | 1984-05-24 | Biologically active tridecapeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
BE902475A true BE902475A (en) | 1985-09-16 |
Family
ID=10561441
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE0/215051A BE902475A (en) | 1984-05-24 | 1985-05-22 | BIOLOGICALLY ACTIVE TRIDECAPEPTIDES. |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPS6197A (en) |
BE (1) | BE902475A (en) |
DE (1) | DE3518086A1 (en) |
GB (2) | GB8413272D0 (en) |
-
1984
- 1984-05-24 GB GB848413272A patent/GB8413272D0/en active Pending
-
1985
- 1985-05-20 DE DE19853518086 patent/DE3518086A1/en not_active Ceased
- 1985-05-21 JP JP60107084A patent/JPS6197A/en active Pending
- 1985-05-21 GB GB08512761A patent/GB2156822A/en not_active Withdrawn
- 1985-05-22 BE BE0/215051A patent/BE902475A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE3518086A1 (en) | 1985-11-28 |
JPS6197A (en) | 1986-01-06 |
GB8512761D0 (en) | 1985-06-26 |
GB2156822A (en) | 1985-10-16 |
GB8413272D0 (en) | 1984-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Johnson et al. | Regulation of lymphokine (gamma-interferon) production by corticotropin. | |
FR2571967B1 (en) | PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING THE BODY. | |
Brunda et al. | Inhibition of experimentally‐induced murine metastases by recombinant alpha interferon: correlation between the modulatory effect of interferon treatment on natural killer cell activity and inhibition of metastases | |
ATE63813T1 (en) | PHARMACEUTICAL COMPOSITIONS OF DIHYDROCODEINES/IBUPROFEN AND PROCESSES. | |
PT76502A (en) | Process for the preparation of n-glycosylated carboxamide derivatives with s stimulating effect of the body's inherent defences and their application for the preparation of pharmaceutical compositions having a stimulating effect of body's inherent defences | |
ATE125706T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING DIPHOSPHONATES FOR THE TREATMENT OF ARTHROSIS. | |
ATE123381T1 (en) | ADMINISTRATION OF ACTIVE INGREDIENTS TO AQUATIC ANIMALS USING SUPERSONIC. | |
ES8500894A1 (en) | Method and compounds for treating inflammatory bowel disease | |
PT78275B (en) | PROCESS FOR THE PREPARATION OF NOVEL 4-FLAVIUM-CARBOXYLIC ACIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | |
BE902475A (en) | BIOLOGICALLY ACTIVE TRIDECAPEPTIDES. | |
ATE40793T1 (en) | PHARMACEUTICAL PREPARATION FOR THERAPEUTIC TREATMENT OF RHEUMATIC DISEASES. | |
FR2529081B1 (en) | THERAPEUTIC COMPOSITION BASED ON 5-HYDROXYDECANOIC ACID OR A DERIVATIVE THEREOF FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | |
DE3861494D1 (en) | PHARMACEUTICAL COMPOSITION FOR TUMOR TREATMENT. | |
FR2601030B1 (en) | ACID COMPOSITIONS WITH HIGH CONCENTRATIONS OF ACTIVE MATERIALS FOR THE TREATMENT OF WATER AND / OR THE CLEANING OF THE FACILITIES CONTAINING THEM | |
DE3275060D1 (en) | Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs | |
FR2412313A1 (en) | PHARMACEUTICAL COMPOSITION BASED ON MONO-SACCHARIDE AND AMINO-ACID FOR ORAL ADMINISTRATIVE USE TO HUMANS | |
Cohen et al. | Enhancement of adrenocorticotrophic activity | |
JPS646214A (en) | Remedy for ulcerative colonopathy | |
FI914410A0 (en) | CALCIUMUPPTAGANDE INHIBITORER. | |
FR2649864B1 (en) | PROCESS FOR THE TREATMENT OF FOIE GRAS OR OTHER ANIMAL FLESH PARTS INTENDED FOR CONSUMPTION | |
JPS53104714A (en) | Compound proteins having serum calcium decreasing, immunity promoting actions and their preparation | |
RO94153A2 (en) | CURATIVE MEDICINE FOR TREATMENT OF LIVER PLANTS IN ALL ANIMAL SPECIES | |
FR2633628B1 (en) | PROCESS FOR THE PREPARATION OF POLYLACTONES OF POLY - (((ALPHA) -HYDROXY- (ACRYLIC AND / OR CROTONIC)) ACIDS) | |
KR890007737A (en) | Anti-caking agents | |
BE905706A (en) | HERBICIDE MIXTURES AND THEIR USE FOR THE TREATMENT OF CROPS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Owner name: FARMITALIA CARLO ERBA S.P.A. Effective date: 19900531 |